More than 650 rules and regulations! Start of negotiation within the scope of classified price limit

Pharmaceutical network June 25 June 24 is the night before the first batch of 3579 generic drugs classified and limited price online enterprises and the results of drug qualification examination and approval are announced and closed in Jilin Public Resources Trading Center The reporter found that Yufengningxin dropping pills of Tongrentang, Xiaochaihu granules of Sichuan Daqian Pharmaceutical Co., Ltd., RNA for injection II of Jilin Aodong Pharmaceutical Co., Ltd., Zhejiang Runge Pharmaceutical Co., Ltd were responsible for bidding, and daewoong of South Korea was responsible for bidding Cefmetazole sodium for injection produced by pharmaceutical Co., Ltd and Hebei Tianzhi Pharmaceutical Co., Ltd were responsible for bidding, while 653 drugs such as sodium chloride injection produced by Tangshan Jixiang Pharmaceutical Co., Ltd and children's cold granules produced by Yadong biopharmaceutical Co., Ltd failed to pass the examination That is to say, if relevant actions are not taken within the publicity period, these products will not be able to reach Jilin market for at least one year Reasonable price comparison, medical institutions are the main body of price negotiation At the same time, Xuesaitong injection of Yunnan Baiyao group, Zhenkening granules of Zhengxin Pharmaceutical Co., Ltd of Guizhou bailing group, ornidazole sodium chloride injection of Sichuan Kelun Pharmaceutical Co., Ltd., ceftazobactam sodium for injection of Kangzhi Pharmaceutical Co., Ltd., omeprazole sodium for injection of Lizhu group Lizhu Pharmaceutical Co., Ltd., cefuroxime sodium for injection of Fu Ren Pharmaceutical Co., Ltd., Huahua Nearly 3000 drugs including cycloester Erythromycin Tablets of runshuanghe Pharmaceutical Co., Ltd passed the examination According to the plan of Jilin Province, the drugs participating in this procurement project are classified and price limited online procurement, including price linked and price limited online procurement and direct price limited online procurement After the relevant drugs of the enterprise win the bid and hang on the Internet, they negotiate with the medical institutions within the price limit, and purchase centrally through the pharmaceutical machinery purchase service platform of Jilin Public Resources Trading Center according to the agreed purchase price It is reported that in principle, the price source of drugs in the price linkage limited price online purchase catalogue is the current provincial bid online price in Jilin Province, Liaoning Province and Heilongjiang Province If there is no provincial bidding price in any of the three provinces, the price source shall be adjusted to the lowest provincial bidding price in China The price source of drugs in the catalogue of direct price limit online purchase is the lowest price of winning the bidding online in all provinces In the price limit rules, the reporter noted that this time Jilin referred to the average value of the bid price of neighboring Heilongjiang and Liaoning provinces If the average value is lower than the current purchase price of Jilin, then the average value will be taken as the price limit, that is to say, Jilin's bid price will surely brush out the new low of the province However, compared with other provinces, the price limit rules are not strict, and in principle, the price limit is not higher than the current purchase price of medical institutions in Jilin Province But Jilin Province also said it could not collect prices from Fujian, Guangdong, Chongqing and the army The difference is that, according to the rules, the planned purchase price of drugs of the same manufacturer, the same common name, the same dosage form, different specifications and packaging should, in principle, conform to a reasonable price comparison relationship; while the planned purchase price of drugs of the same type, the same dosage form and specifications, and different manufacturers should not, in principle, have a large gap In the purchase cycle, if the purchase price is found to be unreasonable, price correction and dynamic adjustment shall be carried out During the procurement cycle, drugs that are adjusted to other procurement methods by relevant departments at or above the provincial level shall be implemented in accordance with relevant regulations According to the plan, the procurement cycle shall not be less than one year, and the price of the online varieties shall be dynamically managed within the procurement cycle In terms of how to formulate the procurement catalogue, Jilin made it clear that this classified and limited price online procurement of drugs will be based on the national basic drug catalogue, Jilin Medical Insurance and new rural cooperative medical insurance reimbursement catalogue, basic drug clinical application guide, prescription set, etc., and in accordance with the clinical needs of medical institutions, reasonably prepare the catalogue and formulate the procurement plan According to the analysis of market participants, it can be seen from this list that the list is based on the list of successful drug procurement in Jilin Province in 2013 Priority should be given to basic drugs, medical insurance (NCMS), drugs with lower prices, and drugs that pass the quality and efficacy consistency evaluation of generic drugs At the same time, we also focus on drugs that conform to the clinical pathway, are included in the major disease guarantee, major public health projects and major infectious diseases In line with the payment policies of medical insurance and NCMS reimbursement, we will promote the standardization of drug dosage forms, specifications and packaging, improve the concentration of drug procurement and use, and select drugs that are commonly used in clinical practice, with appropriate dosage forms and specifications, and easy to package and use It is worth noting that Jilin Province proposes to give full play to the role of medical consortia and specialty alliance, and encourages medical consortia and specialty alliance to be organized and led by the leading unit of medical consortia In medical consortia and specialty alliance, it is possible to try out directory and price unification It can be seen from the relevant requirements of the purchase catalogue that the basic drugs, medical insurance varieties and varieties that pass the consistency evaluation will become the key selection factors, and the standardization of clinical routes and dosage forms is also an important basis These requirements highlight the trend of clinical rational drug use.